Since these radiological changes were insufficient to differentiate PVOD from other PAH types, a genetic testing by whole exome sequencing was performed, which identified a novel EIF2AK4 mutation at c.4833_4836dup(p.Q1613Kfs*10) (Table 2). The gene discussed is EIF2AK4; the disease is pulmonary arterial hypertension.